C
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G66.5 KBCUBIST PHARMACEUTICALS INCFeb 17, 9:51 AM ET·0001011438-15-000102
- SC 13G/A9.4 KBCUBIST PHARMACEUTICALS INCFeb 13, 10:09 AM ET·0000315066-15-001866
- SC 13G/A39.6 KBCUBIST PHARMACEUTICALS INCFeb 10, 11:05 AM ET·0000932471-15-003642
- SC 13G/A9.3 KBCUBIST PHARMACEUTICALS INCFeb 10, 9:28 AM ET·0000315066-15-001577
- 431.0 KBCUBIST PHARMACEUTICALS INCJan 21, 5:09 PM ET·0001104659-15-003772
- 423.4 KBCUBIST PHARMACEUTICALS INCJan 21, 5:09 PM ET·0001104659-15-003771
- 412.0 KBCUBIST PHARMACEUTICALS INCJan 21, 5:09 PM ET·0001104659-15-003770
- 418.6 KBCUBIST PHARMACEUTICALS INCJan 21, 5:09 PM ET·0001104659-15-003768
- 421.1 KBCUBIST PHARMACEUTICALS INCJan 21, 5:08 PM ET·0001104659-15-003767
- 418.5 KBCUBIST PHARMACEUTICALS INCJan 21, 5:08 PM ET·0001104659-15-003766
Insiders
10- BATE KENNETHDirector
- BAYH SUSAN BDirector
- BONNEY MICHAEL WDirector, President and CEO
- CLARKE JOHN KDirector
- CORRIGAN MARKDirector
- DesRosier ThomasSVP, Chief Legal Officer & GC
- EISENSTEIN BARRY ISenior Vice President
- Fellows Lindon MSenior Vice President
- FETZER OLIVERSenior Vice President
- GILMAN STEVEN CSVP, Chief Scientific Officer
Tickers
No tickers on record
Addresses
business
65 HAYDEN AVENUE
LEXINGTON, MA, 02421
mailing
65 HAYDEN AVENUE
LEXINGTON, MA, 02421